Construction of a Database for TMA

Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Dec 1, 2022, to Nov 31, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical-related data of thrombotic microangiopathy.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Thrombotic Microangiopathies Blood Platelet Disorders Cytopenia Hematologic Diseases Hemic and Lymphatic Diseases Thrombocytopenia

Sex eligibility

All sexes

Study type

Observational

Primary location

The First Affiliated Hospital of Soochow University

Suzhou, Jiangsu, 215006, China

Location status: Recruiting

Location contact

Yue Han, professor

CONTACT

[email protected]

+86 13901551669

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The patient has elevated lactate dehydrogenase to more than twice the baseline value, platelets less than 20 or decreased by more than 50% within 24 hours, and more than 2% of schistocytes visible on a peripheral blood smear. Alternatively, pathological sections show extensive micro thrombosis.

Exclusion criteria

The investigator considers the subject unable or unwilling to cooperate with the study procedures.

Treatment and study plan

collection data

Other

collection data

Primary outcomes

Number of participants with stroke

Time frame: 5 years from the time of entering the database.

Stroke was assessed with MRI imaging.

Study contacts

Contact information is provided by the study sponsor or research team.

Yue Han, PhD

CONTACT

[email protected]

+86 18913091817

Sponsors and collaborators

Lead sponsor

The First Affiliated Hospital of Soochow University

Other

Registry information

Official study title

Construction of a Database for Thrombotic Microangiopathy

Important dates

Study start: 2022
Primary completion: 2027
Study completion: 2028
First posted: Dec 2, 2022
Registry last updated: Dec 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting